Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2007

01.10.2007 | Research Paper

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

verfasst von: Joanne Kotsopoulos, Jan Lubinski, Henry T. Lynch, Jan Klijn, Parviz Ghadirian, Susan L. Neuhausen, Charmaine Kim-Sing, William D. Foulkes, Pal Moller, Claudine Isaacs, Susan Domchek, Susan Randall, Kenneth Offit, Nadine Tung, Peter Ainsworth, Ruth Gershoni-Baruch, Andrea Eisen, Mary Daly, Beth Karlan, Howard M. Saal, Fergus Couch, Barbara Pasini, Teresa Wagner, Eitan Friedman, Gad Rennert, Charis Eng, Jeffrey Weitzel, Ping Sun, Steven A. Narod, The Hereditary Breast Cancer Clinical Study Group

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case–control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95% CI 0.98–1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.
Literatur
1.
Zurück zum Zitat Pike MC, Krailo MD, Henderson BE et al (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303(5920):767–770PubMedCrossRef Pike MC, Krailo MD, Henderson BE et al (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303(5920):767–770PubMedCrossRef
2.
Zurück zum Zitat Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1):36–47PubMed Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1):36–47PubMed
3.
Zurück zum Zitat Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2(3):133–140PubMedCrossRef Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2(3):133–140PubMedCrossRef
4.
Zurück zum Zitat MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43(2):209–221PubMed MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43(2):209–221PubMed
5.
Zurück zum Zitat Chie WC, Hsieh C Newcomb PA et al (2000) Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151(7):715–722PubMed Chie WC, Hsieh C Newcomb PA et al (2000) Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151(7):715–722PubMed
6.
Zurück zum Zitat Brinton LA, Hoover R, Fraumeni JF Jr (1983) Reproductive factors in the aetiology of breast cancer. Br J Cancer 47(6):757–762PubMed Brinton LA, Hoover R, Fraumeni JF Jr (1983) Reproductive factors in the aetiology of breast cancer. Br J Cancer 47(6):757–762PubMed
7.
Zurück zum Zitat Layde PM, Webster LA Baughman AL et al (1989) The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 42(10):963–973PubMedCrossRef Layde PM, Webster LA Baughman AL et al (1989) The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 42(10):963–973PubMedCrossRef
8.
Zurück zum Zitat Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676–689PubMedCrossRef Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676–689PubMedCrossRef
9.
Zurück zum Zitat Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130PubMedCrossRef Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130PubMedCrossRef
10.
Zurück zum Zitat Narod S, Lynch H, Conway T et al (1993) Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet 341(8852):1101–1102PubMedCrossRef Narod S, Lynch H, Conway T et al (1993) Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet 341(8852):1101–1102PubMedCrossRef
11.
Zurück zum Zitat Wooster R, Neuhausen SL, Mangion J et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265(5181):2088–2090PubMedCrossRef Wooster R, Neuhausen SL, Mangion J et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265(5181):2088–2090PubMedCrossRef
12.
Zurück zum Zitat Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56(1):265–271PubMed Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56(1):265–271PubMed
13.
Zurück zum Zitat Narod SA (2002) Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer 2(2):113–123PubMedCrossRef Narod SA (2002) Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer 2(2):113–123PubMedCrossRef
14.
Zurück zum Zitat Narod SA, Goldgar D, Cannon-Albright L et al (1995) Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64(6):394–398PubMedCrossRef Narod SA, Goldgar D, Cannon-Albright L et al (1995) Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64(6):394–398PubMedCrossRef
15.
Zurück zum Zitat Chang-Claude J, Becher H, Eby N et al (1997) Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123(5):272–279PubMed Chang-Claude J, Becher H, Eby N et al (1997) Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123(5):272–279PubMed
16.
Zurück zum Zitat Rebbeck TR, Wang Y, Kantoff PW et al (2001) Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 61(14):5420–5424PubMed Rebbeck TR, Wang Y, Kantoff PW et al (2001) Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 61(14):5420–5424PubMed
17.
Zurück zum Zitat Hartge P, Chatterjee N, Wacholder S et al (2002) Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history. Epidemiology 13(3):255–261PubMedCrossRef Hartge P, Chatterjee N, Wacholder S et al (2002) Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history. Epidemiology 13(3):255–261PubMedCrossRef
18.
Zurück zum Zitat Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S et al (2003) BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res 5(5):R121–R128PubMedCrossRef Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S et al (2003) BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res 5(5):R121–R128PubMedCrossRef
19.
Zurück zum Zitat Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98(8):535–544PubMed Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98(8):535–544PubMed
20.
Zurück zum Zitat Cullinane CA, Lubinski J, Neuhausen SL et al (2005) Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 117(6):988–991 Cullinane CA, Lubinski J, Neuhausen SL et al (2005) Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 117(6):988–991
21.
Zurück zum Zitat Jernstrom H, Lubinski J Lynch HT et al (2004) Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 96(14):1094–1098PubMedCrossRef Jernstrom H, Lubinski J Lynch HT et al (2004) Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 96(14):1094–1098PubMedCrossRef
22.
Zurück zum Zitat Kotsopoulos J, Lubinski J, Lynch HT et al (2005) Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control 16(6):667–674PubMedCrossRef Kotsopoulos J, Lubinski J, Lynch HT et al (2005) Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control 16(6):667–674PubMedCrossRef
23.
Zurück zum Zitat Rajan JV, Wang M, Marquis ST et al (1996) Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 93(23):13078–13083PubMedCrossRef Rajan JV, Wang M, Marquis ST et al (1996) Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 93(23):13078–13083PubMedCrossRef
24.
Zurück zum Zitat Rajan JV, Marquis ST, Gardner HP et al (1997) Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 184(2):385–401PubMedCrossRef Rajan JV, Marquis ST, Gardner HP et al (1997) Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 184(2):385–401PubMedCrossRef
25.
Zurück zum Zitat Marquis ST, Rajan JV, Wynshaw-Boris A et al (1995) The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11(1):17–26PubMedCrossRef Marquis ST, Rajan JV, Wynshaw-Boris A et al (1995) The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11(1):17–26PubMedCrossRef
26.
Zurück zum Zitat Vidarsson H, Mikaelsdottir EK, Rafnar T et al (2002) BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity. FEBS Lett 532(1–2):247–252PubMedCrossRef Vidarsson H, Mikaelsdottir EK, Rafnar T et al (2002) BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity. FEBS Lett 532(1–2):247–252PubMedCrossRef
27.
Zurück zum Zitat Fan S, Wang J, Yuan R et al (1999) BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284(5418):1354–1356PubMedCrossRef Fan S, Wang J, Yuan R et al (1999) BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284(5418):1354–1356PubMedCrossRef
28.
Zurück zum Zitat Russo J, Rivera R, Russo IH (1992) Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23(3):211–218PubMedCrossRef Russo J, Rivera R, Russo IH (1992) Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23(3):211–218PubMedCrossRef
29.
Zurück zum Zitat Russo J, Russo IH (1994) Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3(4):353–364PubMed Russo J, Russo IH (1994) Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3(4):353–364PubMed
30.
Zurück zum Zitat Russo J, Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11(4):169–178PubMed Russo J, Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11(4):169–178PubMed
31.
Zurück zum Zitat Russo J, Lynch H, Russo IH (2001) Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 7(5):278–291PubMedCrossRef Russo J, Lynch H, Russo IH (2001) Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 7(5):278–291PubMedCrossRef
32.
Zurück zum Zitat Xu X, Wagner KU, Larson D et al (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22(1):37–43PubMedCrossRef Xu X, Wagner KU, Larson D et al (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22(1):37–43PubMedCrossRef
33.
Zurück zum Zitat Eisen A, Lubinski J, Klijn J et al (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case–control study. J Clin Oncol 23(30):7491–7496PubMedCrossRef Eisen A, Lubinski J, Klijn J et al (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case–control study. J Clin Oncol 23(30):7491–7496PubMedCrossRef
Metadaten
Titel
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
verfasst von
Joanne Kotsopoulos
Jan Lubinski
Henry T. Lynch
Jan Klijn
Parviz Ghadirian
Susan L. Neuhausen
Charmaine Kim-Sing
William D. Foulkes
Pal Moller
Claudine Isaacs
Susan Domchek
Susan Randall
Kenneth Offit
Nadine Tung
Peter Ainsworth
Ruth Gershoni-Baruch
Andrea Eisen
Mary Daly
Beth Karlan
Howard M. Saal
Fergus Couch
Barbara Pasini
Teresa Wagner
Eitan Friedman
Gad Rennert
Charis Eng
Jeffrey Weitzel
Ping Sun
Steven A. Narod
The Hereditary Breast Cancer Clinical Study Group
Publikationsdatum
01.10.2007
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2007
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9441-3

Weitere Artikel der Ausgabe 2/2007

Breast Cancer Research and Treatment 2/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.